@FiercePharma: Rep slaps King with the latest overtime suit. Story | Follow @FiercePharma
Slideshow: Notorious Names in Biopharma. Slideshow
Special Report: Top 10 Women in Biotech. Article
Special ReporT: Pharma's Biggest Flops. Report
> Bayer's third-quarter profit rose 12 percent as sales at its plastics unit, the laggard last year among its three divisions, soared on a recovery in demand from carmakers and manufacturers; the pharma division's sales dropped. Article
> AstraZeneca workers have agreed to suspend their five week protest over pension schemes so "calm" talks with AZ bosses can take place. Item
> Savient Pharmaceuticals, which has failed to entice a buyer since it received regulatory approval for a promising new gout drug last month, tried to reassure investors that it can launch the new medicine on its own. Report
> Eisai, the maker of the Pariet stomach ulcer treatment, predicted full-year profit will rise the most in a decade because of stronger demand for the drug in Japan and lower sales and administrative costs. News
> Sihuan Pharmaceutical surged on its Hong Kong trading debut after a HK$5.75 billion ($741 million) initial public offering to investors including George Soros as it raised funds for acquisitions. Story
> Novartis won an appeals court bid in Paris to uphold the French portion of its European patent for extended-wear lenses, defeating claims by Johnson & Johnson to overturn the intellectual-property protection. Item
> Rival drugmakers Novo Nordisk (NOVOb.CO) and Sanofi-Aventis (SASY.PA) still have all to play for in the multi-billion-dollar long-acting insulin market after a new product from the Danish group failed to show a clear edge. Article
> Botox maker Allergan will face its fifth and sixth lawsuits early next year from plaintiffs who claim the drug caused severe health problems. Article
> Shareholders of Perrigo are getting a 12 percent boost in their dividends. Report
Biotech News
@FierceBiotech: Novartis doubles Boston expansion to $600M. Story | Follow @FierceBiotech
> Biocon makes $161M Malaysian R&D investment. Report
> Acadia, Biovail end Parkinson's drug deal. Story
> Pfizer's lung cancer drug crizotinib shows early promise. Article
> Accentia, Biovest emerge from bankruptcy. News
> Oncolytics raises $24M for cancer trial. Report
Vaccine News
> Vax panel votes to add meningitis booster dose. Story
> Inviragen starts Colombian Phase I dengue trial. Report
> Sinovac cuts full-year revenue forecast. Article
> Bivalent polio vax reduces cases by 90 percent. Item
> Sanofi reports positive results with Fluzone intradermal. News
Manufacturing News
> Regulators triple-team API makers worldwide. Report
> Survey: Raw material link weakens supply chains. Story
> Drug shortages soar amid worsening financials. News
> FDA sharpens import inspection tools. Article
> GMP disregard costs GSK $750M. Item
> Report: Archimedes anesthetic used in Arizona execution. Story
And Finally... Patients are suffering from shortages of some key drugs, including cancer therapies and anesthetics. Story